期刊文献+

S-西酞普兰草酸盐含量测定 被引量:2

Quantitative analysis of S-citalopram oxalate by chiral liquid chromatography
下载PDF
导出
摘要 目的:拆分西酞普兰草酸盐对映异构体,建立S-西酞普兰草酸盐的质量检测方法。方法:采用Chiro-biotic V手性柱(250mm×4.6mm,5μm),以甲醇-冰醋酸-三乙胺(100:0.1:0.1)为流动相;检测波长为240nm,桂温为20℃,流速为1.0min·mL-1。结果:S型和R型异构体获得完全分离,S-西酞普兰草酸盐在10-150μg·mL-1范围内具有良好线性,r=0.999 1(n=5)。螬论:该方法简便、准确,可测定S-西酞谱兰草酸盐的含量。 Objective: To separate the enantiomers of citalopram oxalate and determinate S-citalopram axalate by HPLC. Methods: The chromatographic conditions were as follows: a Chirobiotic V column( 250mm×4. 6mm, 5μm), methanol-acetic acid-triethylamine (100:0.1:0.1) as a mobile phase,detection wavelength at 240nm, the column temperature at 201 and flow rate at 1.0mL·min-1. Results: The enantiomers of citalopram oxalate was successfully separated.The linearity of S-citalopram was 10-150μg·mL-1 with a regression coefficient at 0. 999 1 ( n = 5). Conclusion: This quantitative analysis of S-citalopram oxalate is attained.
出处 《中国新药杂志》 CAS CSCD 北大核心 2004年第11期1020-1021,共2页 Chinese Journal of New Drugs
关键词 手性拆分 S-西酞谱兰草酸盐 高效液相色谱法 enantiomer separation S-citalopram oxalate HPLC
  • 相关文献

参考文献7

  • 1[1]Masilamani S,Ruppelt SC.Escitalopram (Lexapro) for depression[J].Am Fam Physician,2003,68(11):2235-2236.
  • 2[2]Croom KF,Plosker GL.Escitalopram:a pharmacoeconomic review of its use in depression[J].Pharmacoeconomics,2003,21(16):1185-1209.
  • 3[3]Lepola UM,Loft H,Reines EH.Escitalopram (10~20mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care[J].Int Clin Psychopharmacol,2003,18(4):211-217.
  • 4[4]Svensson S,Mansfield PR.Escitalopram:superior to citalopram or a chiral chimera?[J].Psychother Psychosom,2004,73(1):10-16.
  • 5[5]Hyttel J,Bogeso KP,Perregaard J,et al.The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer[J].J Neural Transm Gen Sect,1992,88(2):157-160.
  • 6[6]Kosel M,Eap CB,Amey M,et al.Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography[J].J Chromatogr B Biomed Sci Appl,1998,719(1-2):234-238.
  • 7郑志昌,UlrichKlotz.西酞普兰及其代谢物的对映体稳态血药浓度[J].贵阳医学院学报,2000,25(3):238-240. 被引量:14

二级参考文献5

  • 1[1]Milne R J, Goa KL. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs, 1991, 41: 450-446
  • 2[2]Baumann P, Larsen F. The pharmacokinetics of citalopram. Rev Contemp Pharmacother, 1995, 6:287-95
  • 3[3]Hyttel J, Bogeso KP, Perregaad J, et al. The pharmacological effect of citalopram residues in the (S)-(+)-enantiomers. J Neural Transm GenSect, 1992, 88:157-160
  • 4[4]Rochat R. Amey M, Baumann P. Analysis of enantiomers of citalopram and its demethylated metaholites in plasma of depressive patients using chiral reverse phase liquid chromatograhpy. Therapeutic Drug Monitoting , 1995, 17:273-279
  • 5[5]Bertilson L. Geographical/Interracial differences in polymorphic drug oxidation-Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet, 1995, 29:192-209

共引文献13

同被引文献34

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部